Dan Durant

Title: **Innovative Contributions of Dan Durant in Ophthalmic Technology**

Introduction

Dan Durant, an accomplished inventor based in Rancho Santa Margarita, CA, has made significant strides in the field of ophthalmic technology. With a total of three patents to his name, he has focused his efforts on innovations that enhance patient safety and improve surgical outcomes. His work reflects a deep understanding of both engineering and medicine, contributing valuable insights to the medical community.

Latest Patents

Among Dan's notable inventions is a patent titled "Light exposure quantification strategy for preventing light toxicity during an ophthalmic procedure." This innovative system allows for the quantification of light exposure on a patient's retina during surgical procedures. The mechanism involves a light source that illuminates the retina, a camera capturing image data, and an electronic control unit (ECU) that analyzes the data. The ECU calculates the cumulative energy spectral density of light exposure and can activate an indicator device if the light toxicity threshold is exceeded, ultimately safeguarding the patient's vision.

In addition to this, Dan has developed an "Electrosurgical system," which includes a generator designed to supply radio frequency (RF) energy for tissue fusion. This advanced system carefully monitors the phase angle of RF energy supplied through an electrosurgical instrument, making real-time adjustments to optimize tissue fusion. The electrosurgical instrument is structured to conduct RF energy effectively while mechanically cutting tissue, showcasing Dan's commitment to innovation in surgical technology.

Career Highlights

Dan has honed his expertise through his work with distinguished companies such as Applied Medical Resources Corporation and Alcon, Inc. His roles in these organizations have provided him with invaluable experience in medical device development and innovation, allowing him to bring his ideas to fruition. Dan's career reflects a balance of technical skill and a keen awareness of clinical needs in ophthalmology.

Collaborations

Throughout his career, Dan has collaborated with talented colleagues, including Patrick Elliott and Gary M. Johnson. These partnerships have further enriched his projects, combining diverse expertise to tackle complex challenges within the medical device industry. The collaborative atmosphere has been instrumental in promoting creativity and driving advancements in ophthalmic technologies.

Conclusion

Dan Durant's dedication to innovation in ophthalmic procedures has led to groundbreaking patents that enhance patient care and safety. His work serves as a testament to the impact of innovative thinking in medical technology. As he continues to develop new solutions, Dan remains an influential figure in the field, shaping the future of ophthalmic procedures with his pioneering inventions.